Not every bright sign is guidance.

这不是一个关于错误的故事。

这是一个关于确定性的故事。

幻灯片 3:钩子

deaths per year

From a treatment everyone believed worked.

这是一个关于我们如何相信以及我们如何成为的故事错误。

幻灯片 4:观察

Patients with frequent PVCs after MI had 2–5× higher mortality.

400,000+
MI survivors/year
~40%
具有显着的 PVC
160,000
at elevated risk

A massive clinical need. A clear target.

幻灯片 5:响应

Antiarrhythmic drugs were developed, FDA approved,
and prescribed to ~200,000 patients per year.

这个故事中没有出现恶棍。

每个人都根据最佳证据采取行动可用。

PREMISE 1

PVCs after MI predict sudden cardiac death

PREMISE 2

Antiarrhythmic drugs suppress PVCs

PREMISE 3

Suppressing PVCs should prevent sudden death

链条是合乎逻辑的。结论感觉是不可避免的。

Finally, someone asked: "Does suppressing PVCs actually save lives?"

Design
Randomized, double-blind, placebo-controlled
Population
Post-MI patients with asymptomatic PVCs
Intervention
Encainide, flecainide, or moricizine vs placebo
Run-in
Only patients with ≥80% PVC suppression randomized
Primary endpoint
Death or cardiac arrest with resuscitation
Sample size
1,498 patients (encainide/flecainide arms)

Outcome tested: survival. Not assumed. Measured.

幻灯片 8:结果表

数据安全监测委员会提前停止了试验。

Outcome Drug (n=755) Placebo (n=743)
Arrhythmic deaths 33 9
All cardiac deaths 43 16
Total deaths 56 22
Death rate 7.4% 3.0%
Relative Risk of Death: 2.5
95% CI: 1.6 – 4.5 | p < 0.001

完美抑制心律失常的药物增加了死亡率150%。

Outcome
Drug
Placebo
RR (95% CI)
Arrhythmic death
33/755
9/743
3.6 (1.7-7.5)
Cardiac death
43/755
16/743
2.6 (1.5-4.7)
Total mortality
56/755
22/743
2.5 (1.5-4.0)
Overall
56/755
22/743
2.5 (1.5-4.0)
Favors Drug Favors Placebo

Every endpoint shows harm. The entire confidence interval excludes benefit.

Note: Forest plot shows outcomes within CAST, not pooled trials. I² = 0% (consistent harm).

人力成本

Before CAST, ~200,000 Americans per year received these drugs.

≈ 9,000

excess deaths per year — possibly more

Vietnam War: ~6,000 US deaths/year • These drugs: ~9,000+ deaths/year

For every number, a name we will never know.

Look again.

幻灯片 12:重新审视逻辑(带有飞跃)
PREMISE 1

PVCs after MI predict sudden cardiac death

PREMISE 2

Antiarrhythmic drugs suppress PVCs

← THE LEAP
PREMISE 3

Suppressing PVCs should prevent sudden death

抑制标记会修复结果的假设从来都不是

1

PVC 是受损组织的标志,而不是死亡原因

2

The drugs had proarrhythmic effects — triggering deadlier rhythms

3

替代者有所改善,但结果恶化 - 分离的替代者

替代者没有撒谎。我们问了错误的问题。

幻灯片 14:教训
1

生物学合理性不是证据

A logical mechanism doesn't guarantee the expected effect.

2

Surrogate endpoints can mislead

Improving a biomarker doesn't prove improvement in outcomes.

3

Only randomized trials establish causation

Observational data cannot prove intervention effects.

4

共识不是证据证据

200,000张处方、FDA批准和指南都是错误的。

This is why we do meta-analysis: to see past apparent truths.

What appears certain may be wrong.

What everyone believes may be false.

方法的存在是为了让患者不必为我们的信心付出代价。

这就是您来到这里的原因。

Not every bright sign is guidance.

方法保护患者不受我们信心的影响。

← Course Library

Press arrow keys or click to navigate